On profitability, South reported a fourth-quarter GAAP operating margin of 4.76% , down 10 basis points from the prior year, while non-GAAP operating margin was 7.42% , described as relatively flat year over year despite slightly lower gross margin driven primarily by product mix within the distribution and specialty groups.CFO Ron South said fourth-quarter global sales were $3.4 billion , up 7.7% year over year. Sales growth included 5.8% constant-currency growth, 1.9% benefit from foreign exchange, and 0. ...

These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement of the corresponding GAAP measures. Reconciliations between GAAP and non-GAAP measures included in Exhibit B of today's press release can be found in the Financials and Filings section of our Investor Relations website under the Supplemental Information heading and in our quarterly earnings presentation also posted on our Investor Relations website. The content of thi ...

Donald Trump announced on Saturday that he would raise a temporary tariff rate on US imports from all countries from 10% to 15%, less than 24 hours after the US supreme court ruled against the legality of his flagship trade policy.Infuriated by the high court’s ruling on Friday that he had exceeded his authority and should have got congressional approval for the tariffs he introduced last year under the International Emergency Economic Powers Act (IEEPA), the US president railed against the justices who str ...

The Supreme Court on Friday struck down a crucial batch of President Trump’s tariffs – but there are still plenty of high levies on certain industries that will stay in place.Tariffs imposed under the International Emergency Economic Powers Act (IEEPA) to crack down on trade imbalances and fentanyl smuggling surpassed Trump’s presidential authority, the Supreme Court ruled in a 6-3 decision.The ruling does not, however, discard tariffs enacted by the Trump administration using Section 232 of the Trade Expan ...

The US Supreme Court during a rain storm in Washington, DC, US, on Friday, Feb. 20, 2026. Annabelle Gordon | Bloomberg | Getty ImagesThe Supreme Court on Friday ruled that President Donald Trump's country-specific so-called "reciprocal" tariffs are unconstitutional, delivering a win for many consumer companies facing higher import costs.But the ruling doesn't cover all sectors. The Supreme Court reviewed tariffs enacted under the International Emergency Economic Powers Act of 1977, or IEEPA, which the Trump ...

Key Takeaways Cencora will merge MWI with Covetrus in a deal valuing MWI at a $3.5 billion enterprise value.COR will receive $1.25B cash, $800M preferred equity and $1.45B common equity, keeping a 34.3% stake.The combined platform will integrate MWI's supply chain with Covetrus' tech to boost efficiency and growth.Cencora, Inc. (COR) recently announced that it has agreed to merge its wholly owned subsidiary, MWI Animal Health, with Covetrus in a transaction that values MWI at an enterprise value of $3.5 bil ...

Core Viewpoint - McKesson Corporation has shown strong financial performance and stock growth, outperforming both the broader market and sector-specific indices, indicating a positive outlook for the company. Group 1: Company Overview - McKesson Corporation, based in Irving, Texas, distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products primarily in North America, with a market capitalization of $114.5 billion [1]. - The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International [1]. Group 2: Stock Performance - McKesson's shares have outperformed the broader market over the past year, with a growth of 55.2% over the past 52 weeks and 14% year-to-date, compared to the S&P 500 Index's return of 11.8% [2]. - The stock has also outperformed the State Street Healthcare Select Sector SPDR ETF (XLV), which rose by 7.7% over the past 52 weeks [3]. Group 3: Earnings Performance - On February 5, McKesson's shares surged by 16.5% following the release of better-than-expected Q3 2026 earnings, with revenue increasing by 11.4% year-over-year to $106.2 billion, aligning with market expectations [3]. - The adjusted EPS for the quarter was $9.34, surpassing Wall Street estimates, and the company anticipates full-year earnings in the range of $38.80 to $39.20 per share [3]. Group 4: Analyst Expectations - For the current fiscal year ending in March 2026, analysts expect McKesson's EPS to grow by 18.1% year-over-year to $39.03 on a diluted basis, with a strong earnings surprise history [4]. - Among 17 analysts covering McKesson stock, the consensus rating is a "Strong Buy," supported by 13 "Strong Buy" ratings and four "Holds" [4]. Group 5: Price Target and Analyst Ratings - JP Morgan analyst Lisa Gill maintained an "Overweight" rating on McKesson, raising the price target from $983 to $1,107, indicating an 18.4% potential upside from the current price levels [5]. - The mean price target of $965.56 suggests a 3.3% premium to McKesson's current price [5].

Group 1: Investment Strategy - Pale Fire Capital has heavily bet against Coinbase, Tesla, and Robinhood by purchasing put options during the fourth quarter, indicating a strategic shift in its portfolio towards healthcare stocks [1] - The firm initiated a new position in Baxter International, acquiring 2,074,016 shares valued at approximately $39.63 million, which represents 2.66% of its $1.49 billion reportable U.S. equity AUM as of December 31, 2025 [3] Group 2: Company Overview - Baxter International Inc. is a leading provider of essential healthcare products and services, with a broad product suite and global reach, addressing critical needs in patient care across acute hospital settings and home-based therapies [2] - The company operates a global business model focused on the development, manufacturing, and distribution of medical devices and pharmaceuticals to healthcare providers [3] Group 3: Financial Performance - Baxter International reported significant net losses in 2024 and 2025, but fourth-quarter sales from continuing operations rose by 8% on a reported basis and 3% on an operational basis, with international sales growing by 8% year over year on an operational basis [5]

Analysts on Wall Street project that Bausch + Lomb (BLCO) will announce quarterly earnings of $0.35 per share in its forthcoming report, representing an increase of 40% year over year. Revenues are projected to reach $1.38 billion, increasing 8.1% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings ...

Core Insights - Kirin Holdings Co. is a significant player in the beverage industry, competing with major companies like Anheuser-Busch InBev and Asahi Group Holdings, and is seen as an attractive investment option due to its recent financial performance and growth potential [1] Financial Performance - On February 13, 2026, Kirin reported earnings per share of $0.36, surpassing the estimated $0.30, indicating a positive earnings surprise [2][6] - The company's revenue reached approximately $4.44 billion, exceeding the estimated $4.22 billion, showcasing robust financial health [2][6] Growth Potential - Kirin's growth potential is highlighted by its favorable Growth Score and a top Zacks Rank, indicating it as a standout growth stock with the potential for exceptional returns [3] - The company's positive earnings outlook is reflected in its upgrade to a Zacks Rank 2 (Buy), driven by growing optimism about its earnings prospects [4] Valuation Metrics - Kirin's valuation metrics suggest it is a potential value investment, with a price-to-earnings (P/E) ratio of approximately 24.92 and a price-to-sales ratio of about 0.86 [5] - The company's debt-to-equity ratio of approximately 0.84 and current ratio of around 1.35 indicate a balanced financial structure, further supporting its investment appeal [5]